Market needs to see this as a real & viable market disrupter. While surgeons will appreciate it, surgeons alone are not able to get this stock moving upward and I'm afraid we'll remain at a stagnated PPS, which in the end will cause us more dilution if warrants are not in the money. Again respectfully and JMO.
News 
Market Data 
Discover 
